Hongying Zhou

Hangzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

TGFBR2 as a prognostic marker and therapeutic target in benzo(a)pyrene-associated esophageal cancer: insights from multi-omics analysis.

TGFBR2 as a prognostic marker and therapeutic target in benzo(a)pyrene-associated esophageal cancer: insights from multi-omics analysis.

Journal: Toxicology mechanisms and methods

Published: April 28, 2025

Prognostic poteintial of polyamine metabolism-related genes in hepatocellular carcinoma.

Prognostic poteintial of polyamine metabolism-related genes in hepatocellular carcinoma.

Journal: Scientific reports

Published: April 14, 2025

Development of a prognostic immune cell-based model for ovarian cancer using multiplex immunofluorescence.

Development of a prognostic immune cell-based model for ovarian cancer using multiplex immunofluorescence.

Journal: Journal of translational medicine

Published: March 06, 2025

M6A methylation of FKFB3 reduced pyroptosis of gastric cancer by NLRP3.

M6A methylation of FKFB3 reduced pyroptosis of gastric cancer by NLRP3.

Journal: Anti-cancer drugs

Published: January 19, 2024

MG53 alleviates hypoxia/reoxygenation-induced cardiomyocyte injury by succinylation and ubiquitination modification.

MG53 alleviates hypoxia/reoxygenation-induced cardiomyocyte injury by succinylation and ubiquitination modification.

Journal: Clinical and experimental hypertension (New York, N.Y. : 1993)

Published: October 17, 2023

Malignant gastrointestinal neuroectodermal tumor: a case report and literature review.

Malignant gastrointestinal neuroectodermal tumor: a case report and literature review.

Journal: Annals of medicine and surgery (2012)

Published: September 05, 2023

Effects of the CYP3A inhibitors, voriconazole, itraconazole, and fluconazole on the pharmacokinetics of osimertinib in rats.

Effects of the CYP3A inhibitors, voriconazole, itraconazole, and fluconazole on the pharmacokinetics of osimertinib in rats.

Journal: PeerJ

Published: April 27, 2023

KCND2: A prognostic biomarker and regulator of immune function in gastric cancer.

KCND2: A prognostic biomarker and regulator of immune function in gastric cancer.

Journal: Cancer medicine

Published: March 28, 2023

Tislelizumab immunotherapy combined with chemotherapy in the treatment of a patient with primary anterior mediastinal undifferentiated pleomorphic sarcoma with high PD-L1 expression: A case report and literature review.

Tislelizumab immunotherapy combined with chemotherapy in the treatment of a patient with primary anterior mediastinal undifferentiated pleomorphic sarcoma with high PD-L1 expression: A case report and literature review.

Journal: Frontiers in oncology

Published: November 29, 2022

Development and validation of a novel LC-MS/MS method for simultaneous quantitative determination of tyrosine kinase inhibitors in human plasma.

Development and validation of a novel LC-MS/MS method for simultaneous quantitative determination of tyrosine kinase inhibitors in human plasma.

Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences

Published: March 18, 2022

The involvement of Parkin-dependent mitophagy in the anti-cancer activity of Ginsenoside.

The involvement of Parkin-dependent mitophagy in the anti-cancer activity of Ginsenoside.

Journal: Journal of ginseng research

Published: January 13, 2021

Increased ABCC2 expression predicts cisplatin resistance in non-small cell lung cancer.

Increased ABCC2 expression predicts cisplatin resistance in non-small cell lung cancer.

Journal: Cell biochemistry and function

Published: May 14, 2020

Showing 1-12 of 17

Last Updated: 09/26/2026